C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
11/2002
11/28/2002	CA2448084A1 Aza hydroxylated ethyl amine compounds
11/28/2002	CA2447671A1 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002	CA2410628A1 Carbamic acid esters
11/28/2002	CA2410627A1 Glycinamides
11/27/2002	EP1260499A2 Continuous preparation of incorporated photographic amides
11/27/2002	EP1260498A1 Novel color former and recording material
11/27/2002	EP1259485A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/27/2002	EP1114024B1 Urokinase inhibitors
11/27/2002	EP0971875B1 Process for the purification of substituted p-nitrodiphenylethers
11/27/2002	EP0907638B1 4-jod-2 n-(n-alkyl-aminocarbonyl)-aminosulfonyl]-benzoic acid methyl ester and derivatived thereof and method for their production
11/27/2002	EP0900023B1 Substituted aminomethyl phenyl sulphonyl ureas, their production and their use as herbicides and plant growth regulators
11/27/2002	CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/27/2002	CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/27/2002	CN1382045A Inhibitor for 20-hydroxy-eicosatetraenoic acid enzyme
11/27/2002	CN1094924C Process for purifying diphenyl ether compound
11/26/2002	US6486194 Alzheimer's disease
11/26/2002	US6486094 Bis (arylsulfonylaminocarbonylaminobenzoate) compounds and thermosensitive recording materials containing same
11/24/2002	CA2354921A1 Drug evolution: drug design at hot spots
11/22/2002	WO2003101942A1 Amidine substituted aryl and heteroaryl derivatives with an antithrombotic and factor xa inhibiting action
11/22/2002	CA2445571A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
11/21/2002	WO2002092557A1 Method for producing 2-trifluoromethoxy-benzole sulphonamide
11/21/2002	WO2002092556A1 Sulfonamide derivatives
11/21/2002	WO2002092211A2 Bis (perfluoroalkanesulfonyl) imides and their salts as surfactants/additives for applications having extreme environments and methods therefor
11/21/2002	WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002	US20020173469 Protease inhibitors
11/21/2002	DE10123954A1 Production of 2-trifluoromethoxybenzenesulfonamide for use in herbicide synthesis involves low-temperature reaction of trifluoromethoxybenzene with branched lithium alkyl, sulfur dioxide, chlorine and then ammonia
11/21/2002	CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/21/2002	CA2443721A1 Sulfonamide derivatives
11/20/2002	EP1257530A1 Aminosulfonylbiphenyl derivatives
11/20/2002	EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/19/2002	US6482860 Pentafluorobenzenesulfonamides and analogs
11/19/2002	US6482859 Microbicidal N-sulfonylglycin alkynyloxyphenethyl amide derivatives
11/19/2002	US6482849 Inhibitors of α4β1 mediated cell adhesion
11/14/2002	WO2002089785A1 Sulfonamides
11/14/2002	WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	WO2002089740A2 Sulfonamides
11/14/2002	WO2002064550A8 Glucocorticoid receptor modulators
11/14/2002	US20020169206 Substituted biphenyl compounds for the treatment of inflammation
11/14/2002	US20020169192 Peroxisome proliferator activator receptor (PPAR); amino-ethyl- phenyl derivatives
11/14/2002	US20020169185 Quinolinyl and benzothiazolyl modulators
11/14/2002	US20020169164 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
11/14/2002	US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B
11/14/2002	CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1255730A1 Method for the production of nitroethionate
11/13/2002	EP1255724A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
11/13/2002	EP0983232B1 Guanidinylation reagents
11/13/2002	EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002	CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds
11/13/2002	CN1379748A Process for preparing optically active alpha-hydroxy acids and derivatives thereof
11/13/2002	CN1379023A Methylsulfamide kelixiding and its preparing process
11/12/2002	US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/07/2002	WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002	WO2002088073A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2001047866A9 Substituted 1 and 2 naphthol mannich bases
11/07/2002	WO2001036365A3 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
11/07/2002	US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002	US20020165394 Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
11/07/2002	US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002	US20020165262 Methods and products relating to 16-HETE analogs
11/07/2002	US20020165255 Prostaglandin agonists such as (3-(methanesulfonylamino-methyl)-phenoxy)-acetic acid methyl ester for preventing/ restoring bone mass loss
11/07/2002	US20020165236 Such as 3-(3-(4-(4-sulfamoyl-benzylsulfamoyl-phenyl)-ureido)-benzamidine for treatment of malaria
11/07/2002	US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165223 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders
11/06/2002	EP1254885A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
11/06/2002	EP1254659A1 Stable emulsion compositions
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/05/2002	US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476056 Antiinflammatory agents, psychological disorders
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
10/2002
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085303A2 Substituted tetracycline compounds for the treatment of malaria
10/31/2002	WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002	US20020161041 Resorcinol derivatives
10/31/2002	US20020161011 Potassium channel inhibitors
10/30/2002	EP1253139A2 Multioligoanilinated fullerenes
10/30/2002	EP1253128A1 Perfluoroisopropylbenzene derivatives
10/30/2002	EP1004573B1 Aryloxyaniline derivatives
10/30/2002	CN1377268A Cell adhesion inhibitors
10/29/2002	US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472393 Serine protease inhibitors
10/24/2002	WO2002083630A1 Oxalic acid derivatives
10/24/2002	WO2002083629A1 Bissulfonamide derivatives as inhibitors of dehydroquinate synthetases and type ii dehydroquinases
10/24/2002	WO2002083608A2 Methods of preparing sulfinamide and sulfoxides
10/24/2002	US20020156311 Glucocorticoid receptor modulators
10/24/2002	US20020156094 Sulfonamide interleukin-1beta converting enzyme inhibitors
10/24/2002	US20020156018 Treating parasitic diseases, which are mediated by such proteases. In particular, treating malaria by inhibiting the cysteine protease falcipain.
10/24/2002	CA2445538A1 Oxalic acid derivatives
10/23/2002	EP1250321A1 Glyburide composition

1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 177